high
Sell
15,167 shares
$1,061,690
Significance
6/10
PTCT director Okey sells 15,167 shares at $70.00 for $1.1M, reducing stake 65.5% to 8,000 shares
Director Stephanie Okey executed 2 separate sales totaling 15,167 shares for $1,061,690.00, reducing her holdings from 23,167 shares to 8,000 shares (a 65.5% reduction). The sales occurred at $70.00 per share on 2026-03-10, while the stock currently trades at $63.36 (26.5% below the 52-week high of $86.25). PTC Therapeutics shows strong fundamentals with $211.0M in latest-quarter revenue and 114.5% annual revenue growth, but the 30-day price decline of 12.2% and 90-day decline of 16.2% frame this sale against recent weakness. The substantial reduction in her voting stake warrants scrutiny given the company's growth trajectory.